Evidence map›Paper›PMID 39470887›Full record

ArticleJournal of robotic surgery2024

Urine leak and vascular complications following robotic partial nephrectomy: a contemporary single-center experience.

Olivia Kola, Michael Smigelski, Shavy Nagpal, Rozalba Gogaj, Samir S Taneja, James S Wysock, William C Huang

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Journal of robotic surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07232927 (Evaluation of Hemostatic Agents in Partial Nephrectomy), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07232927 nacompletednot on this map

Evaluation of Hemostatic Agents in Partial Nephrectomy: A Prospective Randomized Trial

TypeinterventionalSponsorAnkara UniversityRan2023 to 2024Enrolled150ConditionsPartial Nephrectomy, Hemostatic Agents, Localized Renal Cell CarcinomaArmsStandard Parenchymal Suturing, Suturing with FloSeal®, Suturing with Surgicel®
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Olivia KolaRutgers New Jersey Medical School, Newark, NJ, USA.
Michael SmigelskiDepartment of Urology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Shavy NagpalDepartment of Urology, New York University Langone Medical Center, Cancer Institute, 150 East 32 Street, New York, NY, 10016, USA.
Rozalba GogajDepartment of Urology, New York University Langone Medical Center, Cancer Institute, 150 East 32 Street, New York, NY, 10016, USA.
Samir S TanejaDepartment of Urology, New York University Langone Medical Center, Cancer Institute, 150 East 32 Street, New York, NY, 10016, USA.
James S WysockDepartment of Urology, New York University Langone Medical Center, Cancer Institute, 150 East 32 Street, New York, NY, 10016, USA.
William C HuangDepartment of Urology, New York University Langone Medical Center, Cancer Institute, 150 East 32 Street, New York, NY, 10016, USA. william.huang@nyumc.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urine leak (UL) and vascular complications (VC), i.e., pseudoaneurysms and arteriovenous fistulas are well-described complications of robotic-assisted partial nephrectomy (RAPN). Historically, UL incidence ranges from 0.3 to 17% and VC from 0.8 to 5.6%. We report the contemporary experience of UL and VC from a single, high-volume center in cases of RAPN. 447 patients were identified from an IRB-approved Renal Tumor Database of 2174 cases who underwent RAPN from 1/2017 to 5/2023. VC occurred in 9 cases (4 pseudoaneurysms, 1 AV fistula, 4 concurrent AV fistula/pseudoaneurysm), UL occurred in 9 (2.0%), and there was one concurrent case of VC and UL. Collecting-system entry occurred in five VC cases and five UL cases. For VCs, the median nephrometry score and maximal tumor diameter was 8 (IQR 3.0) and 3.8 (0.9) cm, respectively, and 8 (3.0) and 3.7 (1.1) cm for UL cases, respectively. Most complications occurred with tumors ≤ 4 mm from the collecting system (n = 7 VC, n = 6 UL). VCs presented after 18 (6.0) days, 6 with gross hematuria; 3 required clot irrigation, 1 required continuous bladder irrigation, and 8 required embolization. No patients required postoperative transfusion. Patients with UL presented after a median of 1 (12) day, with 5 cases detected by elevated creatinine in drain fluid and the remainder detected on routine ultrasound. The duration of UL was 13 (41) days with only 2 cases requiring stenting and one case requiring a drainage catheter. No patients required kidney re-operation or removal. Our rate of VC and UL following RAPN are low and consistent with other contemporary series. Complications occurred in patients with high nephrometry scores or tumors located close to the collecting system. Both complications generally present early and can be managed without kidney re-operation or removal.

Indexed as

Aneurysm, FalseArteriovenous FistulaKidney NeoplasmsNephrectomyPostoperative ComplicationsRobotic Surgical ProceduresAgedFemaleHumansMaleMiddle AgedRetrospective StudiesUrineArteriovenous fistulaPartial nephrectomyPostoperative complicationsPseudoaneurysmUrine leak

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.